Home › Atrial Fibrillation › Idaho
Atrial Fibrillation clinical trials in Idaho
3 studies for Atrial Fibrillation are looking for participants at sites in Idaho.
Cities in Idaho
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
- St Luke's Regional Medical Center, Ltd, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06716021The Fourth Left Atrial Appendage Occlusion Study
- St Luke's Regional Medical Center, Ltd, Boise
- Kootenai Health Inc., Coeur d'Alene
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Saint Alphonsus Regional Medical Center - Boise, Boise
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.